Berlin - Delayed Quote EUR
Halozyme Therapeutics Inc (RV7.BE)
52.86
-0.18
(-0.34%)
At close: May 2 at 8:08:19 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
479,064
479,064
388,571
240,110
299,440
Investing Cash Flow
-262,723
-262,723
-96,909
-487,005
-406,289
Financing Cash Flow
-218,861
-218,861
-407,987
362,371
77,865
End Cash Position
115,850
115,850
118,370
234,695
119,219
Income Tax Paid Supplemental Data
80,618
80,618
31,756
16,224
--
Interest Paid Supplemental Data
10,565
10,565
11,410
6,107
3,296
Capital Expenditure
-10,696
-10,696
-15,294
-4,810
-1,457
Issuance of Debt
--
--
--
1,072,000
784,875
Repayment of Debt
--
--
-13,483
-447,453
-369,064
Repurchase of Capital Stock
-250,000
-250,000
-402,383
-200,002
-350,058
Free Cash Flow
468,368
468,368
373,277
235,300
297,983
12/31/2021 - 11/2/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade